New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

Clinical trial NCT05117177 · COMPLETED

Trial details

NCT number: NCT05117177
Sponsor: iTeos Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2021-07-01
Primary completion: 2024-05-09
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.